Two 21-year-old MIT dropouts have turned their pivot from healthcare AI into a successful compliance automation startup. Delve, founded by CEO Karun Kaushik and COO Selin Kocalar, just closed a $32 million Series A led by Insight Partners at a $300 million valuation—representing a 10x jump from their $3 million seed round just months ago.

The startup began as an AI-powered medical scribe but pivoted to compliance automation after encountering the expensive and time-consuming HIPAA requirements firsthand. What started as solving HIPAA compliance quickly expanded to the "whole alphabet soup" of regulatory frameworks, including SOC 2, PCI, GDPR, and ISO standards.

Delve's AI agents integrate with companies' existing tools to automate compliance workflows that typically consume hundreds of hours in manual effort. The agents collect evidence, write reports, update audit logs, and track configuration changes across fragmented systems—tasks that traditionally bog down engineers and security professionals in busywork.

The company has grown from 100 to over 500 customers, including AI unicorn Lovable, Bland, and Wispr Flow. With 4 million people globally spending their days taking screenshots and filling spreadsheets for compliance, Delve's vision extends beyond regulatory work to automating "a billion hours" of back-office operations across cybersecurity, risk, and internal governance.

The founders dropped out of MIT during their sophomore year in 2023 after joining Y Combinator.